Topical cyclosporine A therapy for dry eye syndrome-Reference-Cited by-同舟云学术

Topical cyclosporine A therapy for dry eye syndrome

Published:2019-09-13 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

de Paiva Cintia S¹,Pflugfelder Stephen C¹,Ng Sueko M²,Akpek Esen K³

Affiliation:

1. Baylor College of Medicine; Ophthalmology; 6565 Fannin Street, NC 307 Houston Texas USA 77030

2. Johns Hopkins Bloomberg School of Public Health; Department of Epidemiology; 615 N. Wolfe Street, W5010 c/o Cochrane Eyes and Vision Group Baltimore Maryland USA 21205

3. Johns Hopkins University School of Medicine; Wilmer Eye Institute; 600 N. Wolfe Street, Maumenee #317 Baltimore Maryland USA 21287

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010051.pub2/epdf/full

Reference112 articles.

1. Topical cyclosporine A for the dry eye findings of thyroid orbitopathy patients;Altiparmak;Eye (London, England),2010

2. A comparative clinical trial of the efficacy of two different aqueous solutions of cyclosporine for the treatment of moderate-to-severe dry eye syndrome;Baiza-Durán;British Journal of Ophthalmology,2010

3. Topical cyclosporine 0.05% for the treatment of dry eye disease in patients infected with the human immunodeficiency virus;Barreto;Revista Brasileira de Oftalmologia,2009

4. A randomized study of the efficacy and safety of 0.1% cyclosporine A cationic emulsion in treatment of moderate to severe dry eye;Baudouin;European Journal of Ophthalmology,2017

5. Expression of inflammatory markers in dry eye syndrome following 12 months' treatment with topical cyclosporin;Baudouin;Investigative Ophthalmology & Visual Science,2001

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cyclic RGD conjugated PEG-PLGA nanoparticle enhances preventative effect of bilirubin on the development of ultraviolet-B (UVB)-induced cataract;Chemical Engineering Journal;2024-10

2. Analyze interleukin-1β, interleukin-6, and tumor necrosis factor-α levels in dry eye and the therapeutic effect of cyclosporine A;World Journal of Clinical Cases;2024-09-06

3. Improvement in signs and symptoms of severe dry eye disease after dual therapy with high-potency steroids and 0.05% cyclosporine;Annals of Medicine;2024-08-19

4. Establishment of human corneal epithelial organoids for ex vivo modelling dry eye disease;Cell Proliferation;2024-07-03

5. SPARC overexpression in allogeneic adipose-derived mesenchymal stem cells in dog dry eye model induced by benzalkonium chloride;Stem Cell Research & Therapy;2024-07-02